What is Lemierre syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Lemierre Syndrome

Lemierre syndrome is a rare but life-threatening condition characterized by septic thrombophlebitis of the internal jugular vein (or other head and neck veins) with septic emboli, occurring as a complication of oropharyngeal infection, most commonly caused by Fusobacterium necrophorum. 1, 2

Pathophysiology and Causative Organisms

  • Fusobacterium necrophorum is the predominant pathogen, implicated in approximately 10-20% of endemic pharyngitis cases in adolescents and serving as the primary cause of Lemierre syndrome 3, 1
  • Other causative organisms include Fusobacterium nucleatum, anaerobic streptococci, staphylococci, and Klebsiella pneumoniae 4
  • The infection typically originates from pharyngitis or tonsillitis in over 85% of cases, progressing to septic thrombophlebitis of the internal jugular vein (classically) or other head and neck veins 3, 4
  • The syndrome can manifest with thrombosis at various vascular sites beyond the internal jugular vein, including the azygos vein, supporting a broader conceptualization of the disease 5

Patient Population and Clinical Context

  • The syndrome predominantly affects previously healthy adolescents and young adults 1, 2, 6
  • The incidence has increased over the past decade, likely related to decreased antibiotic prescribing for upper respiratory tract infections through antibiotic stewardship programs 4
  • Despite modern treatment, the condition carries considerable rates of in-hospital complications, death, and long-term sequelae 2, 7

Clinical Presentation

Patients present with severe pharyngitis followed by persistent fever, rigors, night sweats, tender lymph nodes, neck pain/swelling, and signs of sepsis 1, 3. Key features include:

  • Initial pharyngitis or tonsillitis that progresses to persistent pyrexia and systemic sepsis several days after the initial infection 6
  • Neck tenderness or swelling indicating internal jugular vein thrombophlebitis 3
  • Respiratory symptoms from septic pulmonary emboli, which represent the most common metastatic infection site 4, 5
  • Septic emboli can seed to distant sites including lungs, joints, skin, liver, spleen, brain, and vertebral bodies 6, 5

When to Suspect Lemierre Syndrome

Clinicians should maintain a high index of suspicion in adolescent and young adult patients presenting with unusually severe pharyngitis, particularly when accompanied by difficulty swallowing, drooling, neck tenderness, or swelling 3, 1. Specific red flags include:

  • Persistent fever and septic syndrome several days after initial pharyngitis 4, 6
  • Neck pain with systemic signs of sepsis 4
  • Respiratory symptoms suggesting septic emboli 5
  • Thrombocytopenia, which is consistent with the thrombogenic properties of F. necrophorum 5

Complications and Prognosis

  • The condition can be fatal or cause disabling sequelae despite treatment 7
  • Common complications include thrombus progression, new peripheral septic embolization, and multi-organ failure requiring intensive care support 7, 6
  • Metastatic infections include pneumonia, pleural empyema, vertebral osteomyelitis, and septic arthritis 4, 5

Diagnostic Urgency

Urgent diagnosis and treatment of Lemierre syndrome is necessary to preclude complications and death 3. The condition requires:

  • Thorough radiological evaluation in patients with persistent oropharyngeal symptoms and unexpected systemic manifestations, even when classic internal jugular vein thrombosis is absent 5
  • Blood cultures to identify F. necrophorum bacteremia 5
  • Imaging to detect internal jugular vein thrombophlebitis and septic emboli 3

Management Principles

  • Prolonged antimicrobial therapy for 3-6 weeks is the mainstay of treatment, typically including metronidazole and β-lactam antibiotics 4, 7
  • Anticoagulation is often used but remains controversial without clear evidence-based guidelines 7
  • Surgical intervention may be necessary for peripheral septic lesions 7
  • Admission to intensive care is common due to multi-organ involvement 6

References

Guideline

Lemierre Syndrome Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lemierre's syndrome: A forgotten and re-emerging infection.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020

Research

Azygos vein thrombosis and vertebral osteomyelitis: A rare variant of Lemierre syndrome.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025

Research

Management of Lemierre Syndrome.

Minerva medica, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.